Skip to content

1 Comment

  1. Richard Lipov
    December 30, 2017 @ 3:02 am

    The information in this blog is not new to the pharmaceutical community, Its been around for years. There are several hundred drug entities currently marketed in the US, and capturing all the DDI’s is herculean task, with many of the DDIs not being clinically significant in some patients and significant in others. Even with more DDI information there would still be the issues of incorporating the data into drug distribution systems..
    I would like to know if currently there are any large hospital pharmacies that document interventions related to DDIs. That would be the place to start with current information on DDIs as documented in product inserts for many Rx drugs.

Leave a Reply

Your email address will not be published. Required fields are marked *

All comments will be reviewed and posted if substantive and of general interest to IAPHS readers.